top of page

Pfizer, BioNTech Announce Positive Results from Trial of COVID-19 Vaccine in Children Ages 5-11



Pfizer Inc. and BioNTech SE today announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11 years of age using a two-dose regimen of 10 micrograms administered 21 days apart, a smaller dose than the 30 micrograms dose used for people 12 and older. Awesome!



Photo Credit: Aziz Acharki


 
 
 

Commentaires


Thanks for submitting!

Stay updated on the latest good newz!

GoodNewzUniversal brings the top positive news about the world, daily. No matter what happens, there is always going to be good news all over the world. This website has assembled it, just for you.

    © 2023 BY ARYAMAN SINHA

    bottom of page